| scholarly article | Q13442814 |
| P2093 | author name string | Koichi Kato | |
| Akifumi Oda | |||
| Eiji Kurimoto | |||
| Tomoki Nakayoshi | |||
| P2860 | cites work | Signal peptide prediction based on analysis of experimentally verified cleavage sites | Q24645296 |
| Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors | Q27628512 | ||
| An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes | Q28301310 | ||
| Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy | Q28550062 | ||
| Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta | Q30319511 | ||
| Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions | Q30320504 | ||
| Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation | Q30406473 | ||
| Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells | Q30850332 | ||
| Rapid on-membrane proteolytic cleavage for Edman sequencing and mass spectrometric identification of proteins | Q33225677 | ||
| Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues | Q34059219 | ||
| N-terminal glutamate to pyroglutamate conversion in vivo for human IgG2 antibodies | Q34719565 | ||
| Pyroglutamate-Aβ 3 and 11 colocalize in amyloid plaques in Alzheimer's disease cerebral cortex with pyroglutamate-Aβ 11 forming the central core | Q35660682 | ||
| Heterogeneity of monoclonal antibodies | Q36935493 | ||
| Amino acid sequence of the beta chain of human fibrinogen: homology with the gamma chain | Q37583259 | ||
| A critical concentration of N-terminal pyroglutamylated amyloid beta drives the misfolding of Ab1-42 into more toxic aggregates | Q39424641 | ||
| Amyloid Plaque in the Human Brain Can Decompose from Aβ(1-40/1-42) by Spontaneous Nonenzymatic Processes | Q40024784 | ||
| Phosphate ions and glutaminyl cyclases catalyze the cyclization of glutaminyl residues by facilitating synchronized proton transfers | Q40932694 | ||
| Cyclic analogs of luteinizing hormone-releasing hormone with significant biological activities | Q40968996 | ||
| Racemization of the Succinimide Intermediate Formed in Proteins and Peptides: A Computational Study of the Mechanism Catalyzed by Dihydrogen Phosphate Ion | Q41613730 | ||
| Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain | Q41981559 | ||
| Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid. | Q42477420 | ||
| Computational insight into the mechanism of serine residue racemization | Q43011465 | ||
| Glutaminyl cyclases display significant catalytic proficiency for glutamyl substrates | Q43239720 | ||
| Specific catalysis of asparaginyl deamidation by carboxylic acids: kinetic, thermodynamic, and quantitative structure-property relationship analyses | Q43863484 | ||
| Role of phosphate and carboxylate ions in maillard browning | Q44768070 | ||
| Kinetic study of racemization of aspartyl residues in synthetic elastin peptides | Q45122910 | ||
| Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies | Q46091062 | ||
| Deamidation of asparagine residues: direct hydrolysis versus succinimide-mediated deamidation mechanisms. | Q46157873 | ||
| The removal of pyroglutamic acid from monoclonal antibodies without denaturation of the protein chains | Q46548727 | ||
| Computational evidence for the catalytic mechanism of glutaminyl cyclase. A DFT investigation | Q46602224 | ||
| Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies | Q46628201 | ||
| Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics | Q46811900 | ||
| Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease | Q47133483 | ||
| Comparison of the activation energy barrier for succinimide formation from α- and β-aspartic acid residues obtained from density functional theory calculations | Q47228054 | ||
| High-yield deblocking of amino termini of recombinant immunoglobulins with pyroglutamate aminopeptidase | Q47869327 | ||
| The beta chain of chicken fibrinogen contains an atypical thrombin cleavage site | Q48229416 | ||
| Synthesis and biological activity of some analogs of the gonadotropin releasing hormone | Q48576266 | ||
| Receptors for thyrotropin-releasing hormone in prolactin producing rat pituitary cells in culture. | Q48631878 | ||
| Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain | Q48917681 | ||
| Synthesis and relationship of L-glutaminyl-L-histidyl-L-prolinamide to the thyrotropin releasing hormone | Q48923192 | ||
| Phosphate-Catalyzed Succinimide Formation from Asp Residues: A Computational Study of the Mechanism. | Q51766352 | ||
| Conformation-dependent racemization of aspartyl residues in peptides. | Q51919448 | ||
| Kinetic study of racemization of aspartyl residues in model peptides of alpha A-crystallin. | Q52300136 | ||
| Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. | Q53203663 | ||
| beta-amyloid is different in normal aging and in Alzheimer disease. | Q53271609 | ||
| Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry. | Q53539714 | ||
| Receptor-binding affinities and biological activities of analogs of thyrotropin-releasing hormone in prolactin-producing pituitary cells in culture. | Q54671185 | ||
| Phosphate-Catalyzed Succinimide Formation from an NGR-Containing Cyclic Peptide: A Novel Mechanism for Deammoniation of the Tetrahedral Intermediate | Q58696582 | ||
| Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene | Q67279868 | ||
| Amino acid sequence of the amino-terminal region of calf skin collagen | Q69359465 | ||
| Stabilization of Lysozyme against Irreversible Inactivation by Suppression of Chemical Reactions | Q71941845 | ||
| Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain | Q73067058 | ||
| Intervertebral disc collagen. Usage of the short form of the alpha1(IX) chain in bovine nucleus pulposus | Q73327528 | ||
| Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides | Q79351990 | ||
| Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development | Q79860325 | ||
| Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature | Q83213152 | ||
| Development of cyclic NGR peptides with thioether linkage: structure and dynamics determining deamidation and bioactivity | Q86648975 | ||
| Possible Mechanisms of Nonenzymatic Formation of Dehydroalanine Residue Catalyzed by Dihydrogen Phosphate Ion | Q92648348 | ||
| Computational Studies on the Nonenzymatic Deamidation Mechanisms of Glutamine Residues | Q92942477 | ||
| P433 | issue | 16 | |
| P304 | page(s) | 9162-9170 | |
| P577 | publication date | 2020-04-13 | |
| P1433 | published in | ACS Omega | Q27727647 |
| P1476 | title | Computational Studies on the Mechanisms of Nonenzymatic Intramolecular Cyclization of the Glutamine Residues Located at N-Termini Catalyzed by Inorganic Phosphate Species | |
| P478 | volume | 5 |
Search more.